René P Buholzer – CEO, Interpharma, Switzerland (September 2020)

Interpharma CEO Dr René P Buholzer outlines the holistic strategy that needs to be put in place to maintain Switzerland’s leading position in innovation, market access and reimbursement challenges for new medicines, and why an open, globalised Europe is key for security of supply.  
The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report